Company filings profile · CIK 0001630113

BIOTRICITY INC. — SEC filings & insider activity.

Real, source-linked SEC EDGAR activity for BIOTRICITY INC. (BTCY): 5 filings in the last 90 days vs 5 in the prior 90 (filing-velocity steady · 1×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.

✔ Verified against the public SEC EDGAR filing record as of Sep 28, 2026. Source-linked, daily-refreshed.

Material 8-K events — BIOTRICITY INC.

8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).

FiledEvent
Sep 28, 2026Departure/Election of Directors or Officers; Financial Statements and Exhibits↗
May 1, 2026Entry into a Material Agreement; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits↗
Feb 18, 2026Results of Operations (earnings); Financial Statements and Exhibits↗
Nov 18, 2025Results of Operations (earnings); Financial Statements and Exhibits↗
Feb 24, 2025Results of Operations (earnings); Financial Statements and Exhibits↗
Nov 20, 2024Results of Operations (earnings); Financial Statements and Exhibits↗
Aug 16, 2024Item 5.07↗
Aug 7, 2024Delisting / Listing-Rule Failure↗
Aug 1, 2024Delisting / Listing-Rule Failure↗

Watch BIOTRICITY INC. automatically

Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.

Insider transactions (Form 4 / 3 / 5)

FiledForm
No insider filings in the current window.

Recent filings

FiledFormDetail
Sep 28, 20268-K Departure/Election of Directors or Officers; Financial Statements and Exhibits ↗
Aug 19, 202610-Q 10-Q ↗
Aug 17, 2026NT 10-Q NT 10-Q ↗
Aug 14, 2026SCHEDULE 13G/A ↗
Jul 14, 202610-K 10-K ↗
Jun 29, 2026NT 10-K NT 10-K ↗
Jun 16, 2026DEF 14C DEF 14C ↗
May 29, 2026PRE 14C PRE 14C ↗
May 12, 2026SCHEDULE 13G/A ↗
May 1, 20268-K Entry into a Material Agreement; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Financial Statements and Exhibits ↗
Feb 18, 20268-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Feb 11, 202610-Q 10-Q ↗
Feb 4, 2026SCHEDULE 13G/A ↗
Dec 19, 2025S-1 S-1 ↗
Nov 18, 20258-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Nov 14, 2025SCHEDULE 13G/A ↗
Nov 14, 202510-Q 10-Q ↗
Aug 14, 202510-Q 10-Q ↗
Aug 12, 2025SCHEDULE 13G/A ↗
Jul 18, 202510-K/A 10-K/A ↗
Jul 15, 202510-K 10-K ↗
Jul 1, 2025NT 10-K ↗
May 15, 2025SCHEDULE 13G/A ↗
Feb 24, 20258-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Feb 20, 202510-Q/A ↗
Feb 19, 202510-Q ↗
Feb 14, 2025NT 10-Q ↗
Feb 4, 2025SCHEDULE 13G/A ↗
Nov 20, 20248-K Results of Operations (earnings); Financial Statements and Exhibits ↗
Nov 14, 2024SC 13G/A SC 13G/A ↗
Nov 14, 202410-Q ↗
Oct 15, 202425-NSE ↗
Aug 19, 202410-Q ↗
Aug 16, 20248-K Item 5.07 ↗
Aug 15, 2024NT 10-Q ↗
Aug 8, 2024SC 13G SC 13G ↗
Aug 7, 20248-K Delisting / Listing-Rule Failure ↗
Aug 5, 2024DEF 14A ↗
Aug 5, 2024DEFA14A ↗
Aug 1, 20248-K Delisting / Listing-Rule Failure ↗